Overview

Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The study will compare the effectiveness of antipsychotic medications for patients with schizophrenia or schizoaffective disorder for whom a medication change may be indicated because of an increased risk of cardiovascular disease.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute of Mental Health (NIMH)
Treatments:
Antipsychotic Agents
Aripiprazole
Olanzapine
Quetiapine Fumarate
Risperidone